#Netherlands #Amsterdam #BMC Medical #Sleep Care #Respiratory Solutions

BMC Medical Showcases Innovations at ERS 2025

BMC Medical, a global leader in solutions for sleep and respiratory disorders, is set to unveil its newest product range at the 2025 European Respiratory Society (ERS) International Congress in Amsterdam from September 28 to October 1. Located at Hall 1, Stand H.13, BMC Medical will highlight three groundbreaking innovations aimed at advancing patient-centered care and enhancing clinical decision-making.

Featured Products

The key products introduced at the event reflect BMC's commitment to improving the quality of life for patients dealing with respiratory issues:

1. 6S Series Masks

The new generation of the 6S series masks has been specifically designed to enhance comfort and fit, ensuring better patient adherence during therapy. This innovation represents a significant leap towards fulfilling the needs of patients undergoing continuous positive airway pressure (CPAP) therapy.

2. G3 A20 CPAP Device

The G3 A20 is an advanced CPAP device that offers improved adaptability and customization options. By optimizing treatment outcomes, this device ensures that patients receive tailored respiratory solutions that meet their unique needs.

3. YH-S900C and YH-S900B Home Sleep Testing Devices

BMC will also showcase its new line of home sleep testing devices, the YH-S900C and YH-S900B. These portable diagnostic tools enable more accessible and precise sleep testing in the comfort of patients' homes, paving the way for improved management of sleep disorders.

Workshop on CPAP Monitoring

In addition to the product showcase, BMC Medical will host a sponsored workshop titled “The Future of CPAP Monitoring: What Needs to Change Today?” scheduled for Tuesday, September 29 from 14:00 to 14:45 in Room E103-104. This session will feature prominent experts, including:

• - Renata Riha (University of Edinburgh, UK)
• - Jean-Louis Pépin (Grenoble University Hospital, France)

The workshop will be chaired by Dr. Ding Zou (University of Gothenburg, Sweden) and Dr. Abdelkebir Sabil (Medical Director, BMC Global, France). Discussions will focus on shifting the traditional compliance goal of “4 hours per night” towards a patient-centered approach that prioritizes outcomes and stratification based on patient phenotype. Key topics will include the integration of telemonitoring, artificial intelligence, and multimodal data to enhance long-term patient outcomes and minimize cardiovascular risks.

About BMC Medical

Founded in 2001, BMC Medical is dedicated to partnering with families worldwide to overcome the discomfort associated with chronic respiratory diseases. The company is committed to delivering high-quality products, professional services, and proactive care, ensuring that patients receive the best possible support in managing their conditions.

Throughout this event, BMC Medical continues its mission to innovate and transform respiratory and sleep medicine, embracing advancements that lead to better health outcomes for patients around the globe.